GW&K Investment Management LLC Sells 15,923 Shares of HealthEquity, Inc. (NASDAQ:HQY)

GW&K Investment Management LLC lessened its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 2.6% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 588,548 shares of the company's stock after selling 15,923 shares during the quarter. GW&K Investment Management LLC owned 0.68% of HealthEquity worth $52,010,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Teachers Retirement System of The State of Kentucky increased its position in HealthEquity by 8.6% during the first quarter. Teachers Retirement System of The State of Kentucky now owns 49,780 shares of the company's stock worth $4,399,000 after acquiring an additional 3,946 shares during the period. Covenant Asset Management LLC bought a new position in HealthEquity during the 1st quarter worth approximately $3,350,000. Private Advisor Group LLC raised its holdings in HealthEquity by 43.8% during the 1st quarter. Private Advisor Group LLC now owns 3,038 shares of the company's stock worth $268,000 after purchasing an additional 926 shares during the last quarter. Segall Bryant & Hamill LLC increased its stake in shares of HealthEquity by 50.7% in the 1st quarter. Segall Bryant & Hamill LLC now owns 100,591 shares of the company's stock valued at $8,889,000 after acquiring an additional 33,844 shares in the last quarter. Finally, Larson Financial Group LLC increased its stake in shares of HealthEquity by 1,366.0% in the 1st quarter. Larson Financial Group LLC now owns 689 shares of the company's stock valued at $61,000 after acquiring an additional 642 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company's stock.

HealthEquity Stock Down 0.6%

Shares of NASDAQ:HQY traded down $0.62 on Monday, hitting $97.08. 693,526 shares of the company traded hands, compared to its average volume of 870,969. HealthEquity, Inc. has a 52 week low of $65.01 and a 52 week high of $116.65. The company has a quick ratio of 4.06, a current ratio of 4.06 and a debt-to-equity ratio of 0.50. The stock has a 50 day simple moving average of $101.65 and a 200-day simple moving average of $98.49. The company has a market cap of $8.39 billion, a PE ratio of 70.86, a PEG ratio of 1.51 and a beta of 0.49.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.81 by $0.16. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%. The firm had revenue of $330.80 million during the quarter, compared to the consensus estimate of $322.25 million. During the same period last year, the company earned $0.80 earnings per share. As a group, research analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Insiders Place Their Bets

In other HealthEquity news, EVP Elimelech Rosner sold 58,000 shares of the firm's stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $112.56, for a total value of $6,528,480.00. Following the transaction, the executive vice president directly owned 75,689 shares of the company's stock, valued at approximately $8,519,553.84. This trade represents a 43.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Michael Henry Fiore sold 1,794 shares of HealthEquity stock in a transaction dated Monday, July 7th. The shares were sold at an average price of $101.73, for a total value of $182,503.62. Following the transaction, the executive vice president directly owned 53,225 shares in the company, valued at approximately $5,414,579.25. The trade was a 3.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 291,744 shares of company stock valued at $32,705,007. Insiders own 1.50% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on HQY shares. The Goldman Sachs Group lifted their price target on shares of HealthEquity from $94.00 to $104.00 and gave the company a "neutral" rating in a research report on Wednesday, June 4th. JMP Securities boosted their price target on shares of HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a report on Wednesday, June 4th. Raymond James Financial restated a "strong-buy" rating and issued a $120.00 price objective (up from $115.00) on shares of HealthEquity in a research note on Tuesday, July 8th. Barrington Research upped their price target on HealthEquity from $112.00 to $125.00 and gave the company an "outperform" rating in a research report on Thursday, June 5th. Finally, Wall Street Zen upgraded HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. One research analyst has rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, HealthEquity presently has an average rating of "Buy" and an average price target of $118.55.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.